Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alignment Healthcare, Inc.ALHC · Entity 4269 | Chief Experience Officer | March 27, 2025 | March 29, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alignment Healthcare, Inc.
Report date March 27, 2025 · Filed March 29, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 678,987 |
Reported balance
After 2025-03-27 transaction · row 1
1 source rowRow 1 · 2025-03-27 · Sale · Disposed 7,225 · Balance 678,987 F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.50 to $18.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
F2: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.50 to $18.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 27, 2025 Filed Mar 29, 2025 00:29 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 7,225 | $17.89 | $129,255.25 |
DisclosureSEC source: 0001628280-25-015517 · wk-form4_1743208185.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 678,987 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.50 to $18.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 01:53 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 2,373 | $16.96 | $40,243.23 |
DisclosureSEC source: 0001628280-25-013963 · wk-form4_1742435595.xml · nonDerivative · entry 3 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 686,212 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 01:53 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,229 | $16.09 | $68,036.15 |
DisclosureSEC source: 0001628280-25-013963 · wk-form4_1742435595.xml · nonDerivative · entry 2 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 688,585 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 01:53 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 25,000 | $17.01 | $425,192.50 |
DisclosureSEC source: 0001628280-25-013963 · wk-form4_1742435595.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 692,814 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.98 to $17.09. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 22:05 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 39,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-013246 · wk-form4_1742249143.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 717,814 F1 · shares: Represents 39,677 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 21:03 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 69 | $15.74 | $1,085.92 |
DisclosureSEC source: 0001628280-25-012660 · wk-form4_1741899779.xml · nonDerivative · entry 2 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 678,137 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.72 to $15.76. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 21:03 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,787 | $15.42 | $73,830.38 |
DisclosureSEC source: 0001628280-25-012660 · wk-form4_1741899779.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 678,206 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.72 to $15.715. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 00:23 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 86,659 | $15.53 | $1,345,814.27 |
DisclosureSEC source: 0001628280-25-011107 · wk-form4_1741306991.xml · nonDerivative · entry 2 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 682,993 F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs. This transaction does not represent a discretionary trade by the reporting person. F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.12 to $16.065. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 04, 2025 Filed Mar 7, 2025 00:23 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 474,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-011107 · wk-form4_1741306991.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 769,652 F1 · shares: Represents shares of common stock that were acquired upon the certification by the Compensation Committee of the Alignment Healthcare, Inc. Board of Directors of the achievement of the performance objectives under performance share units ("PSUs") granted on September 14, 2023. The PSUs were scheduled to vest only if and to the extent that certain performance objectives (health plan revenue growth percentage, at-risk returning member medical benefit ratio and adjusted EBITDA, less capital expenditures) met or exceeded specified targets. In the aggregate, the performance objectives were achieved above target. Fifty percent (50%) of the granted PSUs were fully vested on the reported date of acquisition and fifty percent (50%) will become vested on December 31, 2025, subject to the reporting person's continued service to the Company on such vesting date. Read SEC document |
| January 24, 2025 Filed Jan 25, 2025 01:03 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 14,500 | $14.98 | $217,276.70 |
DisclosureSEC source: 0001628280-25-002551 · wk-form4_1737766996.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 295,444 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.98 to $15.00. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:14 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 10,500 | $14.99 | $157,369.80 |
DisclosureSEC source: 0001628280-25-002400 · wk-form4_1737670444.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 309,944 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.98 to $15.02. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 27, 2024 Filed Nov 29, 2024 23:33 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 35,000 | $12.80 | $448,140.00 |
DisclosureSEC source: 0001628280-24-049487 · wk-form4_1732923223.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,444 F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.62 to $12.89. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 23:06 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 20,500 | $13.06 | $267,699.25 |
DisclosureSEC source: 0001628280-24-045399 · wk-form4_1730847983.xml · nonDerivative · entry 2 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 355,444 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.98 to $13.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 23:06 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,500 | $12.98 | $58,413.15 |
DisclosureSEC source: 0001628280-24-045399 · wk-form4_1730847983.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 375,944 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.98 to $12.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 22:24 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 25,000 | $11.48 | $287,052.50 |
DisclosureSEC source: 0001628280-24-040387 · wk-form4_1726266240.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 380,444 F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.48 to $11.49. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 20:41 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 25,000 | $9.98 | $249,500.00 |
DisclosureSEC source: 0001628280-24-032236 · wk-form4_1721335302.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 405,444 Read SEC document |
| March 28, 2024 Filed Mar 30, 2024 00:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,363 | $4.84 | $21,116.92 |
DisclosureSEC source: 0001209191-24-005136 · doc4.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,444 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.73 to $4.935. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 21:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 18,964 | $5.05 | $95,783.37 |
DisclosureSEC source: 0001209191-24-005035 · doc4.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434,807 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2024 and reported on a Form 4 filed with the SEC on March 15, 2024. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.48 to $5.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 15, 2024 Filed Mar 16, 2024 00:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,326 | $4.89 | $21,158.90 |
DisclosureSEC source: 0001209191-24-004870 · doc4.xml · nonDerivative · entry 2 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,771 F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.77 to $5.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 13, 2024 Filed Mar 16, 2024 00:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 140,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004870 · doc4.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,097 F1 · shares: Represents (i) 70,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; (ii) 18,000 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors; and (iii) 52,190 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2023 fiscal year. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.